Lachlan Fotheringham, Rachael A Lawson, Sarah Urasa, Judith Boshe, Elizabeta B Mukaetova-Ladinska, Jane Rogathi, William Howlett, Marieke C J Dekker, William K Gray, Jonathan Evans, Richard W Walker, Philip C Makupa, Stella-Maria Paddick
Neuropsychological tests associated with symptomatic HIV-associated neurocognitive disorder (HAND) in a cohort of older adults in Tanzania
Journal of the International Neuropsychological Society : JINS
aim describe epidemiological clinical laboratory characteristics clinical progress patients hospitalized heart failure hf started treatment empagliflozin discharge methods performed retrospective observational study patients aged 18 years admitted internal medicine department university hospital jaen jaen spain acute hf 1 may 2022 31 may 2023 patients life expectancy 1 year started treatment empagliflozin admission results included 112 patients mean age 852 65 years 679 women 357 313 nyha functional classes iii iv 732 hf preserved ejection fraction admission 804 taking loop diuretics 706 reninangiotensinaldosterone system inhibitors 491 betablockers 25 mineralocorticoid receptor antagonists admission 946 taking furosemide 152 high doses 366 intermediate doses dose furosemide reduced initiation empagliflozin end followup 134 patients died 938 survivors continued treatment empagliflozin 268 attended emergency department signs symptoms hf conclusion introduction empagliflozin discharge hospital patients admitted hf made possible reduce dose diuretics admission frequency complications expected treatment largely maintained